ClinicalTrials.Veeva

Menu

Deep Needling at Zhongliao Point to Stimulate the Sacral Nerve for the Treatment of Slow Transit Constipation

G

Guoliang Wu

Status

Enrolling

Conditions

Constipation

Treatments

Drug: Oral Mosapride Tablets
Device: Deep Acupuncture at Zhongliao Point to Stimulate Sacral Nerve

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Clinical Study on the Treatment of Colonic Slow Transit Constipation by Deep Acupuncture at Zhongliao Point Stimulating Sacral Nerve

Full description

  1. Observing the clinical efficacy of deep acupuncture at Zhongliao point to stimulate the sacral nerve in the treatment of slow transit constipation of the colon through changes in main research indicators such as defecation frequency, stool shape, and fecal weakness.
  2. Clarify the technical focus and difficulties of deep needling at Zhongliao point to stimulate the sacral nerve in the treatment of colonic slow transit constipation, providing a basis for guiding clinical promotion and treatment.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Meets the diagnostic criteria for Slow transit constipation deficiency of both qi and yin;
  • Age 18-65 years old;
  • I have not been treated with intestinal motility drugs in the past month.
  • Those who have informed consent and voluntarily participate in signing an informed consent form, adhere to medical advice for treatment, and undergo regular follow-up visits.

Exclusion criteria

  • Other Traditional Chinese Medicine Syndrome Differentiation Types of Constipation.
  • Concomitant severe heart, lung, and kidney diseases, neurological diseases, and metabolic diseases;
  • Discovering organic lesions such as colorectal cancer and colorectal hyperplasia through colonoscopy, abdominal pelvic CT, or barium enema;
  • Patients with severe mental illness or mental illness or cognitive impairment.
  • Children, pregnant women, lactating women, and pregnant women.
  • Those who stop taking medication at will or use other medications on their own during treatment, do not follow medical advice for treatment, or have incomplete information that affects the judgment of results, safety, and efficacy.
  • Have a history of abdominal surgery.
  • History of needle sickness.
  • People with a tendency to bleed.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

Treatment group
Experimental group
Description:
Using 0.30mm × 75mm millineedle (produced by Suzhou Medical Equipment Factory, Huatuo brand) deeply punctures the Zhongliao acupoint to reach the sacral nerve. The acupuncture needle is connected using the MuhiStim Sensor nerve stimulator produced by Pajunk in Germany. Connect the positive pole to the left Zhongliao hole and the negative pole to the right Zhongliao hole. The frequency, current, and pulse width of sacral nerve electrical stimulation are 2 Hz, 5mA, and 0.1 ms, respectively.Electroacupuncture stimulates the sacral nerve for 30 minutes, once a day, five times a week. After the treatment, rest for two days before starting the next treatment. Five sessions are considered as one course of treatment, with a total of four courses for four consecutive weeks.
Treatment:
Device: Deep Acupuncture at Zhongliao Point to Stimulate Sacral Nerve
control group
Active Comparator group
Description:
Mosapride citrate tablets (produced by Lunan Beite Pharmaceutical Co., Ltd., with the national drug approval number H19990317), oral administration, 5mg once, three times a day, taken before meals. 5 days is one course of treatment, with 2 days of rest during the treatment period. The total treatment period is 4 weeks, with a total of 4 courses.
Treatment:
Drug: Oral Mosapride Tablets

Trial contacts and locations

1

Loading...

Central trial contact

Wu Guoliang, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems